MARC details
| 000 -LEADER |
| fixed length control field |
11113nam a22004573i 4500 |
| 001 - CONTROL NUMBER |
| control field |
EBC6790689 |
| 003 - CONTROL NUMBER IDENTIFIER |
| control field |
MiAaPQ |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
| control field |
20220525084656.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
| fixed length control field |
m o d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
| fixed length control field |
cr cnu|||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
220504s2021 xx o ||||0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9780323902168 |
| Qualifying information |
(electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| Canceled/invalid ISBN |
9780323899765 |
| 035 ## - SYSTEM CONTROL NUMBER |
| System control number |
(MiAaPQ)EBC6790689 |
| 035 ## - SYSTEM CONTROL NUMBER |
| System control number |
(Au-PeEL)EBL6790689 |
| 035 ## - SYSTEM CONTROL NUMBER |
| System control number |
(OCoLC)1283843242 |
| 040 ## - CATALOGING SOURCE |
| Original cataloging agency |
MiAaPQ |
| Language of cataloging |
eng |
| Description conventions |
rda |
| -- |
pn |
| Transcribing agency |
MiAaPQ |
| Modifying agency |
MiAaPQ |
| 082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER |
| Classification number |
636.08527 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
| Personal name |
Davies, Mike. |
| 245 10 - TITLE STATEMENT |
| Title |
Clinical Signs in Humans and Animals Associated with Minerals, Trace Elements and Rare Earth Elements. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
| Place of production, publication, distribution, manufacture |
San Diego : |
| Name of producer, publisher, distributor, manufacturer |
Elsevier Science & Technology, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2021. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
| Date of production, publication, distribution, manufacture, or copyright notice |
�2022. |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
1 online resource (552 pages) |
| 336 ## - CONTENT TYPE |
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 505 0# - FORMATTED CONTENTS NOTE |
| Formatted contents note |
Intro -- Clinical Signs in Humans and Animals Associated with Minerals, Trace Elements, and Rare Earth Elements -- Copyright -- Dedication -- Contents -- Author biography -- Preface -- Introduction -- Historical perspective -- Role of minerals in the body -- Human foods -- Animal foods -- Deficiencies -- Toxicities -- Carcinogenicity, embryotoxicity, mutagenicity, and teratogenicity -- Species differences -- Exotic/Zoo species -- Lack of awareness in the professions -- Limitations in standards of scientific evidence -- Objectives of this book -- Key features -- Section 1: Clinical signs -- Key to tables -- 8-Hydroxy-2-deoxyguanosine (8-OHdG)-High levels -- Abdominal cramps -- Abdominal distension -- Abdominal pain (colic) -- Abnormal/unusual thoughts -- Abortion -- Abasia -- Acetonemia -- Achlorhydria -- Achromotrichia -- Acne -- Acrodynia -- Acroparesthesia -- Acute airway obstruction -- Acute kidney injury (AKI)/acute renal failure -- Acute tubular necrosis -- Adrenal hypertrophy -- Adrenal insufficiency (Addisons disease -- hypoadrenocorticism) -- Agitation -- Aggressive behavior -- Alanine transaminase (ALT)-Elevation -- Albuminuria (proteinuria) -- Aldolase-Reduced levels -- Alkaline phosphatase-Activity reduced -- Alkaline phosphatase-Increased blood concentrations -- Alkalosis-Metabolic -- Allergic reaction -- Alopecia -- Alveolitis -- Alzheimers disease -- Amblyacousia -- Aminoaciduria -- Aminolevulinic acid dehydratase (ALAD) -- Amyloidosis -- Amyotrophic lateral sclerosis -- Anemia -- Anesthesia -- Androgenic receptor protein expression reduced -- Angiedema -- Angular deformity of long bones -- Anhydremia -- Ankylosis -- Anorexia (decreased food intake -- inappetence) -- Anosmia -- Antler abnormalities -- Antral stenosis -- Anuria -- Anxiety -- Aortic aneurysm/rupture -- Aortic calcification -- Aortic wall thickening/plaques -- Apathy. |
| 505 8# - FORMATTED CONTENTS NOTE |
| Formatted contents note |
Apnoea-Obstructive sleep apnoea -- Appetite increased -- Arched back -- Arginase activity increased -- Argyria -- Arrhythmia -- Arthralgia -- Arthropathy -- Ascites -- Ascorbic acid (vitamin C) levels-Low -- Aspartate aminotransferase-AST-High -- Astasia -- Asthma -- Ataxia -- Atelectasis -- Atherosclerosis -- ATPase activity-Reduced -- Attention span loss -- Autism (ASD) -- Autoimmune disease-Increased prevalence -- Azotemia -- Balance loss/vestibular syndrome -- Baritosis -- Basophil stippling -- Beak abnormalities -- Behavioral changes -- Bilirubin-High blood levels -- Bipartite sternebrum -- Birth rate-Low -- Birth weight-Low -- Blackouts -- Blanching of ears -- Blindness -- Blink reflex loss -- Blisters-Skin -- Blood urea nitrogen (BUN)-High -- Blood volume expansion -- Blood volume loss (severe) -- Blurred vision -- Body fat content-Increased -- Body righting reflexes-Delayed development -- Bone damage -- Bone fragility -- Bone loss -- Bone marrow depression -- Bone marrow hyperplasia -- Bone marrow hypoplasia -- Bone pain -- Bone tumors -- Bone undermineralization (metabolic bone disease, osteomalacia -- osteoporosis -- osteopenia, rickets) -- Bone-Increased mineralization (osteopetrosis) -- Bowel obstruction -- Bradycardia -- Brain degeneration -- Brain development impaired -- Brain hemorrhage -- Brain edema -- Brain spongiosis -- Breathlessness -- Bronchoalveolar lavage (BAL)-Positive findings -- Bronchitis-Chronic -- Bronchial obstruction -- Bronchiectasis -- Bronchopneumonia -- Bronchospasm -- Cachexia -- Cadmiuria-Increase -- Calcinosis: Soft tissue calcification -- Calcium absorption reduced from intestinal tract -- Calcium metabolism-Impaired -- Calculi (urinary) -- Cannibalism -- Carcinogenic effect -- Cardiac arrest -- Cardiac arrhythmia -- Cardiac atrophy -- Cardiac deformities (fetal) -- Cardiac enlargement (cardiomegaly). |
| 505 8# - FORMATTED CONTENTS NOTE |
| Formatted contents note |
Cardiac fibrosis -- Cardiac failure/heart failure -- Cardiac murmurs -- Cardiomyopathy -- Cardiovascular abnormalities -- Caries -- Carpal hyperextension -- Cartilage development compromised -- Catalase activity (reduced) -- Cataracts -- Cecal enlargement -- Central nervous system lesions -- Cerebellar agenesis -- Cerebellar ataxia -- Cerebellar coning (herniation) -- Cerebral edema -- Cerebral palsy -- Cerebrovascular infarction -- Ceruloplasmin (serum)-Reduced -- Cheilitis -- Chest pain -- Chest tightness -- Chewing constantly -- Chewing uncoordinated -- Cholangitis -- Cholesterol ratio change -- Cholinesterase-Reduced activity -- Chondrodystrophy -- Chronic obstructive pulmonary disease (COPD) -- Chvostek sign -- Circling -- Circulatory failure -- Cirrhosis -- Choreoathetosis -- Cleft palate/lip -- Cloacal prolapse -- Club foot -- Clumsiness worsens -- Coagulation/clotting time-Prolonged -- Coagulopathy -- Cognitive impairment/deficits -- Collagen synthesis reduced -- Collapse/fainting/syncope -- Colloid depletion -- Color vision loss (color blindness) -- Coma -- Concentration loss -- Conception rate-Low -- Confusion -- Congenital malformations -- Congestion (eyes) -- Congestion (internal organs) -- Congestion (pulmonary) -- Conjunctivitis -- Conjunctival edema (chemosis) -- Consciousness changes -- Consolidation (lungs) -- Constipation -- Convulsions (fits) -- Copper accumulation in body tissues -- Copper-Low plasma concentrations -- Copper-Low liver concentrations -- Corneal lesions -- Coronary band inflammation -- Cough -- Cracks on palms of hands and soles of feet -- Cranial nerve palsies -- Creatine kinase (CK) -- Creatinine-High blood concentrations -- Cretinism -- Crystalluria -- Curled toe paralysis -- Cyanosis -- Cytochrome C in tissues (decreased amounts) -- Cytochrome CYT P450 change -- Cytokine-Increased activity. |
| 505 8# - FORMATTED CONTENTS NOTE |
| Formatted contents note |
Cytokine suppression -- Cytotoxic effects -- Deafness/hearing loss -- Death -- Decubital ulcers -- Defecation frequency reduced -- Dehydration -- Delayed gastric emptying -- Delirium -- Delusions -- Dementia -- Demyelination nervous tissue -- Dendriform pulmonary ossification -- Dental abnormalities -- Depression -- Depth perception-Loss -- Dermatitis -- Dexterity loss -- Diarrhea/scours -- Dilated pupils/miosis -- Diplopia -- Disorientation (directional) -- Disseminated intravascular coagulation (DIC) -- Dizziness -- DNA (deoxyribonucleic acid) damage -- Dropped wings -- Drowsiness -- Dry mouth -- Dullness -- Duodenal ulcers -- Dwarfism -- Dysarthria -- Dysgeusia -- Dysmenorrhoea -- Dysphagia -- Dysphonia -- Dyspnoea -- Dyspraxia (speech impediment) -- Dystocia -- Ear drooping -- ECG changes -- Eczema -- Edema -- Egg production-Poor quality/reduced -- Electrolyte imbalance -- Emaciation -- Embolism -- Embryotoxicity -- Emotional lability -- Emphysema -- Encephalopathy -- Endomyocarditis -- Endurance activity reduced -- Enteropathy -- Eosinophilia -- Epigastric pain -- Epiphyseal dysplasia -- Epiphyseal plate widened -- Epistaxis -- Erectile dysfunction -- Erythema -- Erythrocyte abnormalities -- Erythrocytopenia -- Erythropoiesis impaired -- Eschar -- Esophageal impaction -- Esophagitis -- Esophageal perforation -- Estradiol hormone-Reduced synthesis -- Estrus abnormalities -- Excitability -- Exhaustion -- Exophthalmia -- Exostosis -- Expectoration -- Extensor rigidity -- Exudate formation -- Eye irritation -- Eyelid drooping -- Facial deformity -- Facial expression changes -- Falling off perch -- Falling to recumbency -- Falls -- Fanconi syndrome -- Fasciculations -- Fatigue -- Fatty liver -- Fat infiltration of muscle -- Feather abnormalities -- Fetal abnormalities -- Fetal death rate increased -- Fetal resorption -- Fetal size reduced -- Fever. |
| 505 8# - FORMATTED CONTENTS NOTE |
| Formatted contents note |
Fibrosis-Tissue -- Fibrous osteodystrophy (replacement bone with fibrous tissue) -- Fin and skin erosions -- Fingernail changes -- Flatus -- Fluid losses -- Flushes -- Folic acid-Low in serum -- Follicle stimulating hormone (FSH)-Increased production -- Food conversion efficacy reduced -- Food intake decreased (anorexia -- inappetence) -- Food intake increased -- Food utilization-Decreased -- Foot pad changes -- Forgetfulness -- Fractures -- Free radical formation -- Fur chewing -- Gait abnormalities -- Gamma-glutamyl transferase (GGT) increased activity -- Gamma-glutamyl transpeptidase -- Gangrene -- Garlic smell on breath/alliaceous breath -- Gastric achlorhydria -- Gastric atrophy -- Gastric carcinoma -- Gastric hemorrhage -- Gastric hyperkeratosis -- Gastric hyperplasia -- Gastrointestinal obstruction -- Gastric pain -- Gastric perforation -- Gastric ulcers -- Gastritis -- Gastrointestinal dysfunction -- Gastrointestinal fibrosis -- Gastrointestinal inflammation and ulceration -- Gastrointestinal tract desquamation/necrosis -- Giant cell infiltration -- Giddiness -- Gill filament degeneration -- Gingivitis -- Gliosis -- Glomerular filtration rate (GFR)-Reduced -- Glomerulonephritis -- Glossitis-Inflamed tongue -- Glucose-6-phosphatase-Decreased -- Glucose tolerance-Impaired -- Glutamic oxaloacetic transaminase in serum (SGOT) -- Glutamic pyruvic transaminase in serum (SGPT)-Increased -- Glutathione peroxidase-In serum decreased activity -- Glutathione peroxidase-In serum increased activity -- Glycosuria -- Goiter -- Gout -- Granulocytopenia -- Granuloma formation -- Growth impairment/retardation/poor weight gain -- GSH-px blood concentration-Decreased -- GSH-R blood concentration-Decreased -- Gum disease -- Hair coat changes -- Halitosis -- Hallucinations -- Headaches -- Head pressing -- Head retention -- Head shaking -- Head tilt -- Head tremors. |
| 505 8# - FORMATTED CONTENTS NOTE |
| Formatted contents note |
Hearing loss. |
| 588 ## - SOURCE OF DESCRIPTION NOTE |
| Source of description note |
Description based on publisher supplied metadata and other sources. |
| 590 ## - LOCAL NOTE (RLIN) |
| Local note |
Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2022. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
| 655 #4 - INDEX TERM--GENRE/FORM |
| Genre/form data or focus term |
Electronic books. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
| Relationship information |
Print version: |
| Main entry heading |
Davies, Mike |
| Title |
Clinical Signs in Humans and Animals Associated with Minerals, Trace Elements and Rare Earth Elements |
| Place, publisher, and date of publication |
San Diego : Elsevier Science & Technology,c2021 |
| International Standard Book Number |
9780323899765 |
| 797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) |
| Corporate name or jurisdiction name as entry element |
ProQuest (Firm) |
| 850 ## - HOLDING INSTITUTION |
| Holding institution |
|
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
| Uniform Resource Identifier |
<a href="https://ebookcentral.proquest.com/lib/vajira-ebooks/detail.action?docID=6790689">https://ebookcentral.proquest.com/lib/vajira-ebooks/detail.action?docID=6790689</a> |
| Public note |
Click to View |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
| Source of classification or shelving scheme |
National Library of Medicine Classification |
| Koha item type |
Electronic books |